Ipratropium and albuterol solution is used to treat chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. The medication is a combination of two medications and is used when people with COPD need more than one medication to prevent airway spasms. Ipratropium and albuterol solution comes in a liquid form and is typically taken four times a day using a nebulizer.
Ipratropium and albuterol solution is approved for treating COPD in people who need more than one medication to prevent airway spasms. The medication is inhaled using a nebulizer (a device that changes liquid medications into fine droplets that are inhaled into the lungs).
As with any medicine, side effects are possible with ipratropium and albuterol solution. However, not everyone who takes the drug will experience side effects. In fact, most people tolerate it quite well. If side effects do occur, in most cases, they are minor and either require no treatment or can easily be treated by you or your healthcare provider. Serious side effects are less common.
Common side effects of ipratropium and albuterol solution include but are not limited to:
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: Approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed September 7, 2007.
Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 7th ed. Philadelphia (PA): Lippincott Williams & Wilkins;2005.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click